N/A
N=101
Pentax Airway Scope (AWS) Intubation
Obesity
Bottom Line
View on ClinicalTrials.gov: NCT00667693 ↗Enrolled (actual)
101
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcome: Primary: Time to Intubation — 26; 38 seconds — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Macintosh laryngoscope (Device); Pentax AWS (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- The Cleveland Clinic
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Intubation |
26; 38 | <0.001 sig |
| SECONDARY Ease of Intubation |
40; 52 | — |
| SECONDARY Successful Intubation on the First Attempt |
45; 43 | — |
| SECONDARY The Number of Patients With Different Number of Intubation Attempts |
45; 44; 4; 3; 0; 3 | — |
| SECONDARY The Number of Patients With Bleeding |
0; 2 | — |
Summary
This study will compare the Macintosh laryngoscope with the Pentax. The Pentax AWS is a novel airway management device that is designed to facilitate laryngoscopy and endotracheal intubation.
Eligibility Criteria
Inclusion Criteria
- subject is at least 18 years old
- BMI between 30 and 50
- scheduled for elective surgery requiring orotracheal intubation
Exclusion Criteria
- a known difficult airway
- loose teeth
- subject pregnancy
- rapid sequence induction required
- subject is unable to give consent
- anesthesiologist considered use of the Pentax AWS to be contraindicated
- special endotracheal tube (ETT) is needed for the case.
Data sourced from ClinicalTrials.gov (NCT00667693). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.